BRPI0910991A2 - piperidinas substituídas como compostos terapêuticos - Google Patents

piperidinas substituídas como compostos terapêuticos

Info

Publication number
BRPI0910991A2
BRPI0910991A2 BRPI0910991A BRPI0910991A BRPI0910991A2 BR PI0910991 A2 BRPI0910991 A2 BR PI0910991A2 BR PI0910991 A BRPI0910991 A BR PI0910991A BR PI0910991 A BRPI0910991 A BR PI0910991A BR PI0910991 A2 BRPI0910991 A2 BR PI0910991A2
Authority
BR
Brazil
Prior art keywords
therapeutic compounds
substituted piperidines
piperidines
substituted
therapeutic
Prior art date
Application number
BRPI0910991A
Other languages
English (en)
Inventor
Aleksandar Stojanovic
Dirk Behnke
Peter Herold
Robert Mah
Stefan Stutz
Stjepan Jelakovic
Vincenzo Tschinke
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0910991A2 publication Critical patent/BRPI0910991A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0910991A 2008-04-02 2009-04-01 piperidinas substituídas como compostos terapêuticos BRPI0910991A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08153929 2008-04-02
PCT/EP2009/053898 WO2009121914A1 (en) 2008-04-02 2009-04-01 Substituted piperidines as therapeutic compounds

Publications (1)

Publication Number Publication Date
BRPI0910991A2 true BRPI0910991A2 (pt) 2016-01-19

Family

ID=40627638

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0910991A BRPI0910991A2 (pt) 2008-04-02 2009-04-01 piperidinas substituídas como compostos terapêuticos

Country Status (10)

Country Link
EP (1) EP2271644A1 (pt)
JP (1) JP2011516453A (pt)
KR (1) KR20110002459A (pt)
CN (1) CN101970431A (pt)
AU (1) AU2009232012A1 (pt)
BR (1) BRPI0910991A2 (pt)
CA (1) CA2719070A1 (pt)
EA (1) EA201001517A1 (pt)
MX (1) MX2010010876A (pt)
WO (1) WO2009121914A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011057160A2 (en) * 2009-11-06 2011-05-12 The Regents Of The Uiversity Of California Method to improve the immunogenicity of vaccine antigens by modification of cleavage sites in hiv-1 gp 120
PE20121172A1 (es) 2009-10-14 2012-09-05 Merck Sharp & Dohme Piperidinas sustituidas con actividad en la hdm2
GB201008209D0 (en) * 2010-05-17 2010-06-30 Senexis Ltd Compounds
US8987274B2 (en) 2011-10-28 2015-03-24 Merck Sharp & Dohme Corp Macrocycles that increase p53 activity and the uses thereof
KR102196882B1 (ko) 2012-12-20 2020-12-30 머크 샤프 앤드 돔 코포레이션 Hdm2 억제제로서의 치환된 이미다조피리딘
CN105001300A (zh) * 2014-04-17 2015-10-28 复旦大学 组织蛋白酶d抑制剂及其制备方法、药物组合物和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1816122A3 (en) * 2006-01-19 2007-09-19 Speedel Experimenta AG 3,4,5-substituted piperidines as therapeutic compounds
EP1911758A1 (en) * 2006-10-04 2008-04-16 Speedel Experimenta AG Phenyl piperidine derivatives for use as renin inhibitors
EP1908761A1 (en) * 2006-10-04 2008-04-09 Speedel Experimenta AG Organic compounds

Also Published As

Publication number Publication date
CN101970431A (zh) 2011-02-09
CA2719070A1 (en) 2009-10-08
MX2010010876A (es) 2010-10-26
JP2011516453A (ja) 2011-05-26
EA201001517A1 (ru) 2011-04-29
KR20110002459A (ko) 2011-01-07
EP2271644A1 (en) 2011-01-12
WO2009121914A1 (en) 2009-10-08
AU2009232012A1 (en) 2009-10-08

Similar Documents

Publication Publication Date Title
EP2320907A4 (en) THERAPEUTIC COMPOUNDS
EP2268285A4 (en) THERAPEUTIC COMPOUNDS
BRPI0922845A2 (pt) pirazol-4-n-alcoxicarboxamidas como microbiocidas
CR10926A (es) Nuevas 2-aminooxazolinas como ligandos taar1
DK2288375T3 (da) Pegylerede insulin-lispro-forbindelser
BRPI0920707A2 (pt) compostos
DK2242759T3 (da) Forbindelser
BRPI0913879A2 (pt) fenilpirazinonas como inibidores de quinase
BRPI0916931A2 (pt) agentes terapêuticos
EP2320221A4 (en) ELECTRODE
BRPI0911347A2 (pt) gama lactamas substituídas como agentes terapêuticos
DK2326651T3 (da) Buprenorphinanaloger
SMT201600045B (it) Composti tetraciclinici c7-fluoro sostituiti
BRPI0912475A8 (pt) compostos como inibidores de quinase
DK3300729T3 (da) Terapeutiske sammensætninger indeholdende macitentan
DK2297162T3 (da) Forbindelser
BR112012002336A2 (pt) compostos aza-heterocíclicos
LT3150178T (lt) Stimuliavimo aparatas
BRPI0914936A2 (pt) naftiridininonas como inibidores de aurora quinase
BRPI0916432A2 (pt) compostos
EP2427183A4 (en) THERAPEUTIC COMPOUNDS
BRPI1012775A2 (pt) piperidinas substituídas
BRPI0910991A2 (pt) piperidinas substituídas como compostos terapêuticos
DK2206698T3 (da) Ethynylindolforbindelser
BRPI0910931A2 (pt) ciclopentanos substituídos terapêuticos

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired